Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial
Recruiting now · Not applicable
Conditions studied: Heart Failure with Preserved Ejection Fraction, Atrial Fibrillation
In brief
The goal of this clinical trial is to evaluate if a bariatric surgery strategy will improve clinical endpoints, cardiac parameters and functional status in patients with obesity (with BMI 32-40 kg/m2) and symptomatic HF with preserved or mildly reduced LVEF in combination with AF, as compared to standard of care. Patients will be randomized to either the Intervention group receiving bariatric surgery including an intensive pre- and postoperative treatment scheme or to the control group receiving standard of care.
Key facts
- Study ID
- NCT06065124
- Run by
- University Medical Center Groningen
- People needed
- 108
- Starts
- 2024-07-01
- Expected to finish
- 2027-10-01
- Last updated by the study team
- 2025-04-01
Who can join
Age: 45 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Signs and symptoms of HF according to the Europeans Society of Cardiology guideline;
- Left ventricular ejection fraction ≥40%;
- HFA-PEFF score ≥5 or HFA-PEFF score 2-4 in combination with positive stress test;
- Between 45 and 70 years of age;
- BMI 32-40 kg/m2;
- Paroxysmal or persistent AF with a rhythm control strategy;
- Willing to undergo both treatment strategies;
- Written informed consent.
You may not qualify if…
- BMI ≥40 kg/m2;
- BMI <32 kg/m2;
- Patients unwilling or unable to sign informed consent;
- More than moderate mitral valve regurgitation/aortic valve regurgitation;
- More than mild mitral valve stenosis/aortic valve stenosis;
- Inadequate echocardiographic window for the assessment of LV mass index and/or the echocardiographic criteria needed for the HFA-PEFF score;
- History of myocardial infarction, myocarditis, any invasive cardiac intervention (e.g. surgery, percutaneous coronary intervention, ablation) or stroke, <3 months before inclusion;
- Scheduled for AF ablation;
- Complex congenital heart disease;
- Negative treatment advise from a specialized psychiatrist due to non-stabilized psychotic disorders, severe depression and/or personality disorders;
- Patients unable to care for themselves or who are unable adapt to inherent lifestyle changes following bariatric surgery;
- Any medical condition that limits life span <2 years;
- Diseases requiring long term use of anti-inflammatory treatments;
- The use of medication associated with substantial effects (>5 kg) on body weight.
Where it is running
- University Medical Center Groningen — Groningen, Provincie Groningen, Netherlands (enrolling)
- Rijnstate Hospital — Arnhem, Gelderland, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.